Target intelligence / Profile preview

Unidentified reticulocyte receptor recognized by PvAMA-1

Molecular classification
Receptor, Membrane protein
01

Overview

The unidentified reticulocyte receptor recognized by Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) is a host cell surface protein essential for the invasion of human reticulocytes by the malaria parasite. While PvAMA-1 is well-known for its interaction with the parasite-derived protein RON2 to form a moving junction, recent evidence indicates it also binds directly to a host receptor on the reticulocyte membrane. This interaction is critical for the initial attachment and reorientation of the merozoite during the invasion process. Targeting this receptor-ligand interaction with monoclonal antibodies or vaccines is a major strategy for developing blood-stage malaria interventions. Although the exact molecular identity of this host receptor has historically been unknown, recent research has identified KREMEN1 as a functional receptor for AMA-1 across multiple Plasmodium species, including P. vivax. Its role in the strict tropism of P. vivax for immature red blood cells makes it a high-priority therapeutic target for preventing clinical malaria symptoms.

Other names
PvAMA-1 host receptorUnknown reticulocyte receptor for PvAMA-1PvAMA1-binding erythrocyte proteinKREMEN1 (putative)
02

Mechanism of action

Blocking the interaction between PvAMA-1 and its host receptor prevents the formation of the moving junction and inhibits the invasion of reticulocytes by Plasmodium vivax merozoites.

03

Biological functions

Cell adhesionHost-parasite interactionMerozoite invasion
04

Disease associations

InfectionMalaria
05

Safety considerations

Potential for off-target effects if the receptor has critical physiological functions in humansHigh genetic diversity of PvAMA-1 may lead to immune evasionTherapeutic challenges due to the lack of a continuous in vitro culture system for P. vivax
06

Interacting drugs

humAb 826827

1 more in the full profile.

07

Biomarkers

CD71 (Transferrin receptor 1)

Beyond the preview

Go deeper on Unidentified reticulocyte receptor recognized by PvAMA-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unidentified reticulocyte receptor recognized by PvAMA-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call